Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Operating Leases: 2019-2024

Historic Operating Leases for CorMedix (CRMD) over the last 5 years, with Dec 2024 value amounting to $349,091.

  • CorMedix's Operating Leases rose 333.68% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 million, marking a year-over-year increase of 333.68%. This contributed to the annual value of $349,091 for FY2024, which is N/A change from last year.
  • According to the latest figures from FY2024, CorMedix's Operating Leases is $349,091, which was down 56.53% from $803,000 recorded in FY2022.
  • CorMedix's Operating Leases' 5-year high stood at $923,708 during FY2020, with a 5-year trough of $349,091 in FY2024.
  • Over the past 2 years, CorMedix's median Operating Leases value was $576,046 (recorded in 2022), while the average stood at $576,046.
  • Its Operating Leases has fluctuated over the past 5 years, first spiked by 34,392.46% in 2020, then declined by 13.13% in 2021.
  • Over the past 4 years, CorMedix's Operating Leases (Yearly) stood at $923,708 in 2020, then fell by 13.13% to $802,433 in 2021, then increased by 0.07% to $803,000 in 2022, then reached $349,091 in 2024.